Key result
Maternal cardiomyopathy is linked to more adverse perinatal outcomes versus no cardiac disease.
Why the study?
Does maternal cardiomyopathy increase the risk of adverse perinatal outcomes compared to noncardiomyopathy cardiac disease or no cardiac disease?
Does maternal cardiomyopathy increase the risk of adverse perinatal outcomes compared to noncardiomyopathy cardiac disease or no cardiac disease?
Maternal cardiomyopathy is associated with an increased risk of adverse perinatal outcomes, highlighting the need for detailed preconception counseling and multidisciplinary pregnancy management.
Answers are grounded in this paper and cite their sources.
Supports multidisciplinary monitoring and preconception counseling in maternal cardiomyopathy; confirms higher perinatal risks than noncardiomyopathy cardiac disease.
There was an increased likelihood of adverse perinatal outcomes in pregnancies affected by maternal cardiomyopathy compared with both pregnancies affected by noncardiomyopathy cardiac disease and pregnancies without cardiac disease. Women with cardiomyopathy who plan to get pregnant should receive detailed counseling regarding these risks and have their pregnancies managed by experienced multidisciplinary teams that can provide close fetal monitoring and neonatology expertise.
No takes yet. Share an insight, caveat, or question.
Eggleton et al. (2022) studied this question. Pregnancies affected by maternal cardiomyopathy are more likely to experience adverse perinatal outcomes compared to those without cardiac disease.
Synapse has enriched 10 related papers. Consider them for comparative context: